Mary Tagliaferri

Mary Tagliaferri

Teknisk/Vetenskaplig/F&U Direktör på NEKTAR THERAPEUTICS
60 år
Health Technology
Consumer Services
Finance

Profil

Mary A. Tagliaferri was the founder of Bionovo, Inc., founded in 2002, where the titles held included President, Secretary, Treasurer & Director from 2011 to 2012.
Current jobs include Director at Iambic Therapeutics, Inc. starting in 2024 and Chief Medical Officer at Nektar Therapeutics starting in 2025.
Former jobs include Director at Atossa Therapeutics, Inc., Independent Director at Rayzebio, Inc. from 2021 to 2024, Independent Director at Enzo Biochem, Inc. from 2023 to 2024, Independent Director at Y-mAbs Therapeutics, Inc. from 2024 to 2025, Secretary, Treasurer & Chief Regulatory Officer at Lighten Up Enterprises International, Inc., and Chief Medical Officer at Kanglaite USA, Inc. from 2012 to 2014.
Education includes an undergraduate degree from Cornell University in 1988, a graduate degree from American College of Traditional Chinese Medicine in 1995, and a doctorate from The University of California, San Francisco in 2002.

Aktiva positioner av Mary Tagliaferri

FöretagPositionStart
NEKTAR THERAPEUTICS Teknisk/Vetenskaplig/F&U Direktör 2025-09-01
Direktör/Styrelseledamot 2024-09-19

Tidigare kända positioner av Mary Tagliaferri

FöretagPositionSlut
YMAS THER Direktör/Styrelseledamot 2025-07-11
ENZO BIOCHEM, INC. Ordförande 2023-10-25
RAYZEBIO, INC. Direktör/Styrelseledamot 2024-02-26
Teknisk/Vetenskaplig/F&U Direktör 2014-06-01
BIONOVO INC. Grundare 2012-06-01
Se detaljerna i Mary Tagliaferris erfarenhet

Mary Tagliaferris utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

86

Första gradens relationer

12

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag12

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Technology Services

  1. Börsen
  2. Insiders
  3. Mary Tagliaferri
- 40% : De bästa verktygen för abonnenter som vill hitta morgondagens bästa investeringar!
d
:
:
TA FÖRDEL AV DET NU